BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 12009250)

  • 21. Redox cycling of bleomycin-Fe(III) by an NADH-dependent enzyme, and DNA damage in isolated rat liver nuclei.
    Mahmutoglu I; Kappus H
    Biochem Pharmacol; 1987 Nov; 36(21):3677-81. PubMed ID: 2445349
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparative binding properties of metallobleomycins with DNA 10-mers.
    Li W; Zhao C; Xia C; Antholine WE; Petering DH
    Biochemistry; 2001 Jun; 40(25):7559-68. PubMed ID: 11412110
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identification and cleavage site analysis of DNA sequences bound strongly by bleomycin.
    Ma Q; Akiyama Y; Xu Z; Konishi K; Hecht SM
    J Am Chem Soc; 2009 Feb; 131(5):2013-22. PubMed ID: 19146404
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sequence-specific double-strand cleavage of DNA by Fe-bleomycin. 1. The detection of sequence-specific double-strand breaks using hairpin oligonucleotides.
    Absalon MJ; Kozarich JW; Stubbe J
    Biochemistry; 1995 Feb; 34(6):2065-75. PubMed ID: 7531498
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Guanine-specific binding by bleomycin-nickel(III) complex and its reactivity for guanine-quartet telomeric DNA.
    Guan LL; Kuwahara J; Sugiura Y
    Biochemistry; 1993 Jun; 32(24):6141-5. PubMed ID: 7685636
    [TBL] [Abstract][Full Text] [Related]  

  • 26. An active intermediate formed in the reaction of bleomycin-Fe(II) complex with oxygen.
    Kuramochi H; Takahashi K; Takita T; Umezawa H
    J Antibiot (Tokyo); 1981 May; 34(5):576-82. PubMed ID: 6168629
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Characterization of bleomycin cleavage sites in strongly bound hairpin DNAs.
    Giroux RA; Hecht SM
    J Am Chem Soc; 2010 Dec; 132(47):16987-96. PubMed ID: 21047076
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Mechanism of action of bleomycin at the molecular level].
    Takita T
    Gan To Kagaku Ryoho; 1984 Dec; 11(12 Pt 2):2659-65. PubMed ID: 6210059
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A short DNA sequence confers strong bleomycin binding to hairpin DNAs.
    Tang C; Paul A; Alam MP; Roy B; Wilson WD; Hecht SM
    J Am Chem Soc; 2014 Oct; 136(39):13715-26. PubMed ID: 25188011
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Kinetics of the reaction of bleomycin-Fe(II)-O2 complex with DNA.
    Ekimoto H; Kuramochi H; Takahashi K; Matsuda A; Umezawa H
    J Antibiot (Tokyo); 1980 Apr; 33(4):426-34. PubMed ID: 6157664
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification of strong DNA binding motifs for bleomycin.
    Akiyama Y; Ma Q; Edgar E; Laikhter A; Hecht SM
    J Am Chem Soc; 2008 Jul; 130(30):9650-1. PubMed ID: 18597467
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cryogenic photolysis of activated bleomycin to ferric bleomycin.
    Burger RM; Usov OM; Grigoryants VM; Scholes CP
    J Phys Chem B; 2006 Oct; 110(41):20702-9. PubMed ID: 17034262
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Interaction of nitrosyl Fe(II) complex of bleomycin with DNA.
    Chikira M; Sakamoto K; Antholine WE
    Nucleic Acids Symp Ser; 1997; (37):99-100. PubMed ID: 9586018
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Activation of bleomycin-Fe(III) by bleomycin-Cu(II) and cysteine.
    Takahashi K; Takita T; Umezawa H
    J Antibiot (Tokyo); 1987 Apr; 40(4):542-6. PubMed ID: 2438263
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The cyclic voltammetric study of iron-tallysomycin in the absence and presence of DNA.
    Sun J; Solaiman DK
    J Inorg Biochem; 1990 Nov; 40(3):271-7. PubMed ID: 1705573
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Properties of the initial reaction of bleomycin and several of its metal complexes with Ehrlich cells.
    Lyman S; Ujjani B; Renner K; Antholine W; Petering DH; Whetstone JW; Knight JM
    Cancer Res; 1986 Sep; 46(9):4472-8. PubMed ID: 2425953
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Synthetic analogues and biosynthetic intermediates of bleomycin. Metal-binding, dioxygen interaction, and implication for the role of functional groups in bleomycin action mechanism.
    Sugiura Y; Suzuki T; Otsuka M; Kobayashi S; Ohno M; Takita T; Umezawa H
    J Biol Chem; 1983 Jan; 258(2):1328-36. PubMed ID: 6185478
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Reduction of chromium(VI) by ascorbate leads to chromium-DNA binding and DNA strand breaks in vitro.
    Stearns DM; Kennedy LJ; Courtney KD; Giangrande PH; Phieffer LS; Wetterhahn KE
    Biochemistry; 1995 Jan; 34(3):910-9. PubMed ID: 7827049
    [TBL] [Abstract][Full Text] [Related]  

  • 39. On the chemistry of RNA degradation by Fe.bleomycin.
    Holmes CE; Duff RJ; van der Marel GA; van Boom J; Hecht SM
    Bioorg Med Chem; 1997 Jun; 5(6):1235-48. PubMed ID: 9222517
    [TBL] [Abstract][Full Text] [Related]  

  • 40. On the mechanism of lipoxygenase-like action of bleomycin-iron complexes.
    Kikuchi H; Tetsuka T
    J Antibiot (Tokyo); 1992 Apr; 45(4):548-55. PubMed ID: 1375591
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.